KCNK2 and encephalomyelitis: Kcnk2 has the potential to reduce encephalomyelitis scores and lymphocyte infiltration into the central nervous system, indicating that drugs targeting the regulation of Kcnk2 activity may be used to treat various BBB injury-related neurological diseases30.